Stock Events

Nascent Biotech 

$0.05
9
+$0+0% Friday 19:47

Statistics

Day High
0.07
Day Low
0.06
52W High
0.28
52W Low
0.05
Volume
301,300
Avg. Volume
54,652
Mkt Cap
10.33M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

10NovConfirmed
Q4 2020
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.01
-0
0
0.01
Expected EPS
N/A
Actual EPS
-0.0012

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NBIO. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Ayala Pharmaceuticals
ADXS
Mkt Cap7.4M
Advaxis, Inc. focuses on the discovery, development, and commercialization of immunotherapy products, a similar field to Nascent Biotech's work in cancer treatment.
Gritstone Bio
GRTS
Mkt Cap70.57M
Gritstone bio, Inc. is involved in developing personalized cancer immunotherapies, directly competing with Nascent's approach to cancer treatment.
Marker Therapeutics
MRKR
Mkt Cap45M
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, working on novel therapies that could compete with Nascent's products.
PDS Biotechnology
PDSB
Mkt Cap141.95M
PDS Biotechnology Corporation is a clinical-stage biopharmaceutical company, developing a similar range of immunotherapies for cancer.
SELLAS Life Sciences
SLS
Mkt Cap64.11M
SELLAS Life Sciences Group, Inc. is involved in developing novel cancer immunotherapies, making it a competitor in the oncology space.

About

Agricultural Commodities/Milling
Process Industries
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. In addition, the company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. Nascent Biotech, Inc. is based in Vero Beach, Florida.
Show more...
CEO
Country
US
ISIN
US63108Q1013

Listings

OTCM
US
NBIO